Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Sarilumab Stories

2014-04-04 16:23:39

TARRYTOWN, N.Y., April 4, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has elected Robert A. Ingram to its Board of Directors. Regeneron also announced that Dr. Eric Shooter, a co-founder of the Company, is retiring from the Board after nearly 26 years of service to Regeneron. Mr. Ingram was nominated to become a member of Regeneron's Board by Sanofi. Under the terms of an investor agreement between Regeneron and Sanofi, Sanofi...

2013-11-22 00:20:42

Sarilumab, Given Subcutaneously Every Other Week, Met All Three Co-Primary Endpoints PARIS and TARRYTOWN, N.Y., Nov. 22, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that in the SARIL-RA-MOBILITY Phase 3 clinical trial in adult patients with active rheumatoid arthritis (RA) who were inadequate responders to methotrexate (MTX) therapy, sarilumab (the first fully-human anti-IL-6R monoclonal antibody) treatment in...

2013-01-04 16:22:15

TARRYTOWN, N.Y., Jan. 4, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 1 million shares, or approximately 1.06%, of the outstanding Regeneron common stock at a price of $161.25 per share. TRC's offer price represents approximately a 4.46% discount to the closing price of Regeneron common stock on December 27, 2012, the last closing price prior to commencement of the...

2012-12-20 12:26:37

TARRYTOWN, N.Y., Dec. 20, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences: Goldman Sachs Healthcare CEOs Unscripted: A View from the Top on Thursday, January 3, 2013. The session is scheduled for 3:15 p.m. Eastern Time. 31(st) Annual J. P. Morgan Healthcare Conference on Tuesday, January 8, 2013. The presentation is scheduled for 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time)....

2012-11-29 16:24:30

TARRYTOWN, N.Y., Nov. 29, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it was named "Biotechnology Company of the Year" by Scrip Intelligence at the 8(th) annual Scrip Awards. The Award recognizes the biotech firm that has achieved the most in the 12 months between June 1, 2011 and May 31, 2012. In presenting the award, Scrip said, "Regeneron has been transformed over the past year by the U.S. approval of its first major product. On the back of...

2012-11-27 12:28:56

TARRYTOWN, N.Y., Nov. 27, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3, 2012. The presentation is scheduled for 1:05 p.m. Eastern Time. The session may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentation will be available for 30 days. Regeneron is a fully integrated biopharmaceutical...

2012-11-06 16:28:46

TARRYTOWN, N.Y., Nov. 6, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences: Lazard Capital Markets 9(th) Annual Healthcare Conference at 11:00 a.m. Eastern Time on Tuesday, November 13, 2012 Credit Suisse Healthcare Conference at 9:30 a.m. Eastern Time (7:30 a.m. Mountain Time) on Wednesday, November 14, 2012 Piper Jaffray 24(th) Annual Healthcare Conference at 12:00 p.m. on Wednesday,...

2012-10-10 11:24:41

TARRYTOWN, N.Y., Oct. 10, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2012 financial and operating results on Wednesday, October 24, 2012, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM EST that day. Conference Call InformationTo access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International). A link to the webcast may be...

2012-09-21 06:25:31

TARRYTOWN, N.Y., Sept. 21, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that Science magazine has ranked Regeneron as the #1 employer in the global biopharmaceutical industry in the journal's annual Top Employers Survey. "This recognition by Science as the most respected company to work for in the biopharmaceutical industry is very satisfying for all of us at Regeneron," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of...

2012-08-29 06:25:00

TARRYTOWN, N.Y., Aug. 29, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences: Robert W. Baird Healthcare Conference at 1:20 p.m. Eastern Time on Wednesday, September 5, 2012 Morgan Stanley Global Healthcare Conference at 3:55 p.m. Eastern Time on Tuesday, September 11, 2012 UBS Global Life Sciences Conference at 7:30 a.m. Eastern Time on Thursday, September 20, 2012 The sessions may be accessed...